Chris graduated with a first class chemistry MSci degree from the University of Nottingham. Spending a year employed as a medicinal chemist at GlaxoSmithKline, he worked on small molecule inhibition of hepatitis C viral proteins.
In the final year of his degree, with the assistance of a research grant from AstraZeneca, Chris’ research project into new synthetic routes to 1,2-benzisoxazole compounds led to a peer reviewed publication of a new synthetic method.
In joining the intellectual property (IP) profession, Chris’ work primarily involves the preparation and prosecution of patent applications in the UK, Europe and worldwide. He has particular experience of advising in relation to invention spotting and the development of new patent portfolios.
Chris works closely with his clients that include universities, start-ups and multinational companies to ensure that their innovation is captured, turned into valuable assets and their commercial interests protected.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.